BRD4 and neoplasm: HA targeted Ppa-NPs activate CD8T+ cells in vivo. PDT-mediated tumour volume reductions and survival rates were highest with HA-targeted NPs containing Ppa and JQ1 (a BRD4 inhibiting drug).Apoptotic cell death was observed with NPs following PDT.